Sleep

Filter Your Results

 

News

 

American Academy of Sleep Medicine Issues Advisory: Insufficient Sleep May Increase Risk for Alzheimer’s Disease

Tuesday, June 05, 2018—The American Academy of Sleep Medicine (AASM) has issued a health advisory warning that insufficient or poor sleep may increase the risk of developing Alzheimer’s diseas…

Patients Treated With Lemborexant Awake and Return to Sleep Safely Without Fall Risk

Tuesday, June 05, 2018—In results presented today at the Associated Professional Sleep Societies meeting (SLEEP 2018, Baltimore, MD) it was shown that patients treated with lemborexant (Eisai, Woodc…

Excessive Sleepiness Impacts More Than Quality of Life: More Awareness Needed

Monday, June 04, 2018—Results from a survey of sleep specialists suggest there is a need for greater awareness of the neurologic effects of excessive sleepiness (ES), including neuronal injury and …

FDA Grants Breakthrough and Fast-Track Designations to Pitolisant for Treatment of Patients With Narcolepsy

Monday, May 21, 2018—The Food and Drug Administration (FDA) has granted fast-track and breakthrough therapy designations to the investigational therapy pitolisant (Harmony Biosciences, Plymouth Me…

Guidance for the Use of Opioids in the Treatment of Refractory Restless Leg Syndrome

Monday, January 08, 2018—On January 8, 2018, Mayo Clinic Proceedings published an article on appropriate use of opioids for treating refractory restless legs syndrome (RLS) by members of the Scientifi…

Sleep Disturbances Linked to Alzheimer’s Disease

Thursday, July 06, 2017—Poor sleep may be a sign that otherwise healthy individuals may have an increased risk of developing Alzheimer’s disease later in life over those who do not have sleep p…

Investigational Narcolepsy Agent Found Effective for Severely Affected Patients with Cataplexy in Phase 3 Study

Thursday, January 26, 2017—Results from a phase 3 controlled trial show that pitolisant (Wakix, Bioproject Pharma) may be efficacious in severely affected narcoleptic patients with cataplexy. Pitolisant…

Upper Airway Stimulation for Sleep Apnea Approved

June 2014 --  Inspire Medical Systems has received marketing approval from the FDA for its Inspire Upper Airway Stimulation (UAS) system. The device is an implantable ne…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC